Abstract:PURPOSE. To investigate the role of leukotriene B4 (LTB4) and its receptor BLT1 in the pathogenesis of mouse uveitis.METHODS. Experimental autoimmune uveitis (EAU) was induced in B10RIII mice by immunization of interphotoreceptor retinoid binding protein (IRBP; peptide sequence 161-180) or in C57BL/6 (B6) mice by transfer of activated T cells specific for IRBP1-20. The animals were then treated with and without the BLT1 receptor antagonist, CP105696, at the disease onset after immunization or at day 0 or day 6 after T-cell transfer. EAU was also induced in wild-type B6 (WT) and BLT1-deficient (BLT1(-/-)) mice by reciprocal transfer of the T cells from B6 to BLT1-deficient mice and vise versa. Clinical signs of inflammation and ocular histology were compared. The chemotactic activity of LTB4 on naive and IRBP-specific autoreactive T cells as well as effector leukocytes was examined.RESULTS. The treatment of CP105696, greatly reduced the intensity of ongoing disease. IRBP1-20-specific T cells derived from wild-type B6 mice induced only mild uveitis in syngeneic BLT1-deficient mice and that IRBP1-20-specific T cells derived from BLT1(-/-) mice induced milder disease in wild-type B6 mice than those derived from wild-type B6 mice, Suggesting that expression of the LTB4 receptor on both activated autoreactive T cells and effector leukocytes was necessary for ocular inflammation to occur. Consistent with these data, transfer of alltoreactive T cells from B6 mice to 5-hpoxygenase-deficient (5-LO-/-) mice, which have it functional defect in LTB4 expression, also failed to induce uveitis in the recipient mice.CONCLUSIONS. The results demonstrate a critical role for LTB4 in ocular inflammation and in the development and progression of EAU and suggest a new potential target for therapeutic intervention in this disease.

An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) Via Dendritic Cell Activation.

Adenosine Receptor Activation in the Th17 Autoimmune Responses of Experimental Autoimmune Uveitis.

Anti-Inflammatory or Proinflammatory Effect of an Adenosine Receptor Agonist on the Th17 Autoimmune Response is Inflammatory Environment–Dependent

A2B Adenosine Receptor Activation Switches Differentiation of Bone Marrow Cells to a CD11c+Gr‐1+ Dendritic Cell Subset That Promotes the Th17 Response

Blocking A(2b) Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Inhibition of Il-6 Production and Th17 Differentiation

High Level Expression of A2ARs is Required for the Enhancing Function, but Not for the Inhibiting Function, of Γδ T Cells in the Autoimmune Responses of EAU

Retinoic Acid Inhibits Cd25(+) Dendritic Cell Expansion And Gamma Delta T-Cell Activation In Experimental Autoimmune Uveitis

Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis.

Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.

Activation of the Adenosine A2A Receptor Attenuates Experimental Autoimmune Myasthenia Gravis Severity.

Engagement of Toll-like Receptor 2 Enhances Interleukin (IL)-17(+) Autoreactive T Cell Responses Via P38 Mitogen-Activated Protein Kinase Signalling in Dendritic Cells.

Adenosine 2a Receptor Signal Blockade of Murine Autoimmune Arthritis via Inhibition of Pathogenic Germinal Center–Follicular Helper T Cells

Apolipoprotein A1 Modulates Teff/Treg Balance Through Scavenger Receptor Class B Type I-Dependent Mechanisms in Experimental Autoimmune Uveitis.

The Role of Th17-associated Cytokines in the Pathogenesis of Experimental Autoimmune Uveitis (EAU).

Blockade of the Interaction of Leukotriene B4 with Its Receptor Prevents Development of Autoimmune Uveitis.

Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development

Rapamycin Ameliorates Experimental Autoimmune Uveoretinitis By Inhibiting Thl/Th2/Th17 Cells And Upregulating Cd4+Cd25+Foxp3 Regulatory T Cells

Role of DAF in Protecting Against T-Cell Autoreactivity That Leads to Experimental Autoimmune Uveitis

Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.

2-Methoxyestradiol Alleviates Experimental Autoimmune Uveitis by Inhibiting Lymphocytes Proliferation and T Cell Differentiation.